 Conference Call Scheduled for Tuesday, August 17 at 11:30 AM EDT NORTHVALE, NJ ACCESSWIRE August 16, 2021 Elite Pharmaceuticals, Inc. Elite or the Company OTCQB:ELTP, a specialty pharmaceutical company developing niche generic products, announced results for the first quarter of fiscal year 2022 ended June 30, 2021 First Quarter. Total revenues for the three-month period ended June 30, 2021 decreased by 0.5 million or 6, to 7.1 million, as compared to 7.5 million, for the corresponding period of the prior year, primarily due to timing of sales of Amphetamine IR Tablets and Amphetamine ER Capsules. 